The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.
"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."
As part of our on-going member support, we are introducing a new website feature to help with common practice management challenges. We welcome your input with questions or challenges you would like to address. Read More
On August 3, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician…
Congress has passed four pieces of legislation and the Centers for Medicare & Medicaid Services…
Implementation of the new USP General Chapter <797> Pharmaceutical Compounding — Sterile Preparations is still…
12/01/24: Research Grant Cycle
Learn more
04/01/25: Fellow Exam Application Deadline
Learn more
06/01/25: Research Grant Cycle
Learn more
08/08/25: Scientific Abstract Submission Deadline
Learn more
Thanks to your feedback, we have reimagined our Advanced Course in Allergy & Immunology to give you educational programming that encompasses your full scope of practice. Join us for the new Explorers Course 2025: Surgical & Medical Management of Airway Disease in Otolaryngology. Learn More
We are pleased to invite you to participate in the 2025 AAOA Annual Meeting Call for Proposals. Do you have burning content ideas to be presented at the Annual Meeting? The AAOA is seeking proposals to incorporate in the educational sessions for the 2025 Annual Meeting. Learn More
For information about Resident membership, opportunities, DosedDaily, research grants, and other resources. Learn More
IFAR Impact Factor: 2.454
IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More
2024 AAOA Annual Meeting - Hybrid
November 8-10, 2024
Four Seasons Hotel Las Vegas
Learn More and Register
Explorers Course 2025:
Surgical & Medical Management of Airway Disease in Otolaryngology — Hybrid
90-days Access Feb 27 – May 27, 2025
March 27-29, 2025 - Live
The Hythe, Vail, CO
Learn More and Register
2025 AAOA Basic Course in Allergy & Immunology - Hybrid
90-days Access June 10 – Sep 15, 2025
July 10-12, 2025 - Live
The Chateaux Deer Valley, Park City, UT
Book Your Room
USP 797 Online Module
Learn More and Register
AAOA Educational Stacks
Available Now!
Keith Sale, MD, AAOA President-Elect, recently testified before the Senate Subcommittee hearing, Avoiding a Cautionary Tale: Policy…
We want to hear from you! We are pleased to invite you to participate in…
The American Medical Association (AMA) is undertaking a new national study, supported by 173 healthcare organizations,…
The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.
AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.
A brief summary of the CMS Coding 2021 – AAOA Zoomcast Series: Just In Time Content for AAOA Members, Part II. Written by Christie DeMason MD, FAAOA. Panelists: James Connolly, MD; Ayesha Khalid, MD, MBA; Nalin Patel, MD; Robert Stachler,…
A brief summary of the Re-Engaging Patients 2021 - AAOA Zoomcast Series: Just In Time Content for AAOA Members, Part II. Written by Jodi Zuckerman MD, FAAOA. Panelists: Steven Houser, MD; Haidy Marzouk, MD; Paul Neubauer, MD; Nalin Patel, MD;…
A brief summary of the COVID-19 Vaccines - AAOA Zoomcast Series: Just In Time Content for AAOA Members, Part II. Written by Haidy Marzouk, MD, FAAOA. *Information related to COVID 19 is rapidly evolving Panelists: Michelle Liu, MD; Nalin Patel,…
By Dana Crosby, MD, FAAOA WHY DO I NEED TO STOP SOME MEDICATIONS BEFORE AN ALLERGY TEST? When you are allergic to a substance, your body releases certain chemicals such as histamine. When these chemicals are released in the skin…
In the third episode of the AAOA’s NEW podcast series Today in ENT Allergy: AAOA’s Podcast, Jennifer Villwock, MD, FAAOA speaks with Gavin Setzen, MD, FAAOA. They are discussing the integral role allergy plays in ENT practice. How and why…
Effective January 1, 2021, the Centers for Medicare & Medicaid (CMS) finalized significant changes to the office and outpatient evaluation and management (E/M) services (CPT codes 99202-99215) for both new and established patients. Specially, CMS increased the valuations for the…
By Jodi Zuckerman MD, FAAOA Currently there are three forms of immunotherapy. After skin testing or blood testing, reactivity can be quantified to a specific allergen such as grass, dust mite, cat, ragweed. Immunotherapy is the process of presenting these…
Joint Statement by the American Academy of Otolaryngology–Head and Neck Surgery (AAO–HNS) and the American Academy of Otolaryngic Allergy (AAOA) Allergic reactions are uncommon and anaphylaxis following vaccines is rare, occurring at a rate of approximately one per million doses…
With the advent of the vaccine comes new questions and concerns. To help you address those with your staff and patients, AAOA has outlined some FAQs and resource links. We will continue to update this FAQ as more information becomes available…
Everyone with asthma needs his or her own Asthma Action Plan. Work with your health care provider to create a plan that works for you. A very useful CDC resource can be found here.
